ArticleCureus2025
Palindromic Minocycline-Induced Vasculitis With Dual-Positivity for Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody (MPO-ANCA) and Anti-DNA Antibody.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long-term usage of minocycline can result in the development of various autoimmune conditions, including vasculitis. We herein report the case of a 23-year-old female patient who developed fever, arthralgia, and erythema of the lower limbs 15 months after the initiation of minocycline. Her symptoms recovered spontaneously within one and a half months but relapsed two months later along with dysesthesia of the lower limbs. Her myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) and anti-DNA antibody were positive, and histology of her skin demonstrated features of necrotizing vasculitis of the small vessels. Minocycline was discontinued, and her symptoms improved without requiring further treatment, along with the normalization of MPO-ANCA and anti-DNA antibody titers. No recurrence was observed nine months after discontinuation, although her lower limb dysesthesia lasted for six months before recovery. Clinicians should bear in mind the possibility of minocycline-induced vasculitis when symptoms of vasculitis are suspected in patients receiving long-term minocycline. An immediate withdrawal of the drug is recommended in such cases to prevent the development of organ-threatening lesions and long-lasting aftereffects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.